Events

MDMA’s FDA Forum OPEN FOR REGISTRATION

1352

Join us at MDMA’s popular TWO day FDA Forum on March 11-12, 2015 in Palo Alto, CA.  This conference will focus on unique insights and strategies to govern the 510(k) and PMA regulatory pathways.  This is a great way for companies considering submitting a 510(k) or PMA to get the tools they need to prepare successful submissions.

Top FDA Speakers Include:
William Maisel, MD., MPH
Deputy Center Director for Science and CDRH Chief Scientist

Barbara Zimmerman
Deputy Director, CDRH, Office of Device Evaluation

Owen Faris *via teleconference
Clinical Trial Director, ODE

Murray Sheldon *via teleconference
Associate Director for Technology and Innovations, CDRH

Topics Include:

  • Navigating Today’s 510(k) Program
  • Clinical Trial Considerations
  • The Growing DeNovo Program
  • PMA Review Considerations
  • MDUFA Independent Assessment Update
  • UDI Implementation

 

We also have a great panel of industry experts for the interactive session, “Applying Lessons Learned/Case Studies.”

Registration Fees:
Day One-PMA/510(k) Workshop Only:
MDMA Member: $295
State Organization Member: $395 (enter code “state”)
NonMember: $495

Day Two-FDA Reform: 2012 & Beyond Only:
MDMA Member: $295
State Organization Member: $395 (enter code “state”)
NonMember: $495

BOTH Days:
MDMA Member: $495
State Organization Member: $595 (enter code “state”)
NonMember: $895
RN

 

 

This seminar is pre-approved by RAPS as eligible for up to 6 credits towards a participant’s RAC recertification upon full completion.